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ARTICLE
Sequencing of high-complexity DNA pools for
identification of nucleotide and structural variants
in regions associated with complex traits
Ghazal Zaboli1,13, Adam Ameur1,13, Wilmar Igl1, A˚sa Johansson1, Caroline Hayward2, Veronique Vitart2,
Susan Campbell2, Lina Zgaga3,11, Ozren Polasek3, Gerd Schmitz4, Cornelia van Duijn5, Ben Oostra6,
Peter Pramstaller7,8,9, Andrew Hicks7, Tomas Meitinger10, Igor Rudan11,12, Alan Wright2, James F Wilson12,
Harry Campbell12 and Ulf Gyllensten*,1, for the EUROSPAN Consortium
We have used targeted genomic sequencing of high-complexity DNA pools based on long-range PCR and deep DNA sequencing
by the SOLiD technology. The method was used for sequencing of 286kb from four chromosomal regions with quantitative trait
loci (QTL) influencing blood plasma lipid and uric acid levels in DNA pools of 500 individuals from each of five European
populations. The method shows very good precision in estimating allele frequencies as compared with individual genotyping of
SNPs (r2¼0.95, Po1016). Validation shows that the method is able to identify novel SNPs and estimate their frequency in
high-complexity DNA pools. In our five populations, 17% of all SNPs and 61% of structural variants are not available in the
public databases. A large fraction of the novel variants show a limited geographic distribution, with 62% of the novel SNPs
and 59% of novel structural variants being detected in only one of the populations. The large number of population-specific
novel SNPs underscores the need for comprehensive sequencing of local populations in order to identify the causal variants
of human traits.
European Journal of Human Genetics (2012) 20, 77–83; doi:10.1038/ejhg.2011.138; published online 3 August 2011
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INTRODUCTION
Genome-wide association studies (GWAS) have identified a large number
of SNPs associated with human diseases and quantitative traits (QTs).1 At
present information for about 19 million SNPs is available in dbSNP (as
of version 130).2 The 300000 to 1000000 SNPs that have been typed in
association studies explains only a small fraction of the phenotypic
variation of the traits.3 One possible reason that most of the phenotypic
variation remains unexplained is that the SNPs on the arrays are biased
towards common variants4 and analysis does not capture the effect of
rare variants. The targeted sequencing by the HapMap 3 Consortium,5
large-scale exome sequencing projects, such as that of 200 exomes of
individuals of Danish origin studied using low-coverage DNA sequen-
cing,6 and the data generated through the pilot phase of the 1000
Genomes Project7 have all emphasized the large number of previously
undetected rare variants present in human populations. Most studies
have included a limited number of individuals per population, and have
therefore identified mainly sequence variants with a medium to low
frequency (5–10%), while identification of SNPs with a frequency below
that requires even larger sample size per population.
Next-generation DNA sequencing (NGS) technologies provide an
opportunity to sequence complete genomes, exomes or large genomic
regions, but the cost is still prohibitive for sequencing of thousands of
individual genomes from a single population.8 An alternative is to
perform targeted sequencing of the DNA of pools of individuals. Ingman
et al9 used long-range PCR (LR-PCR) and Roche Genome Sequencher
(454; Roche Applied Sciences, Werk Penzberg, Germany) for SNP
detection and allele frequency estimation in DNA pools of 96 individuals
and Out et al10 used long-range PCR and a population pool of 287
individuals using Solexa Genome Analyzer (Illumina Inc., San Diego, CA,
USA). Druley et al11 sequenced 13237 bases in a pool of 1111 individuals
and showed a good precision in the frequency estimation for 14 validated
SNPs. A limitation in pools sequencing is that individual genotypes
cannot be deduced. Bansal et al12 used amplicons generated from single
individuals and pooled amplicons from 48 individuals for sequencing on
the Illumina GA. However, handling of amplicons from single individuals
becomes impractical for sequencing of large number of samples from a
population. Prabhu and Peer13 proposed that individual genotypes in a
pool could be identified using a series of overlapping pools to enable
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identification of single alleles. Erlich et al14 used barcoded pools for
identification of the pool from which an allele was obtained and Shental
et al15 developed a method denoted compressed sensing (CS) that is
based on using overlapping pools and suited for identification of rare
alleles both in heterozygous or in homozygous state.
All present next-generation DNA sequencing technologies can be
used for analysis of high-complexity DNA pools. The two-base
encoding system SOLiD technology reduces the frequency of technical
errors, potentially providing an advantage for sequencing of pools.8
Here, we describe a method for detection of genetic variants in high-
complexity DNA pools using the SOLiD technology. We used this
method for identification of SNPs and structural variants (indels) in
DNA pools of about 500 individuals from each of five populations.
The regions sequenced were selected on the basis of associations
previously found between SNPs in these regions and lipid (LASS4,
LIPC and ATP10D)16 or uric acid (SLC2A9) levels.17
METHODS
Populations and genomic regions
The cohorts studied stem from populations in Sweden, Italy, Scotland, Croatia
and The Netherlands and are part of the European Special Population Research
Network (EUROSPAN, http://www.eurospan.org). All participants gave their
written informed consent.18 The Northern Swedish Population Health Study
(NSPHS) is a cross-sectional study conducted in the community of Karesuando
north of the Arctic Circle in the Norrbotten County, Sweden.19 The Orkney
Complex Disease Study (ORCADES) is a longitudinal study in the Scottish
archipelago of Orkney.20 The VIS study is a cross-sectional study in the villages
of Vis and Komiza on the Dalmatian island of Vis, Croatia.21,22 The Micro-
isolates in South Tyrol Study (MICROS) is a cross-sectional study carried out in
the villages of Stelvio, Vallelunga and Martello, Venosta valley, South Tyrol,
Italy.23 The Erasmus Rucphen Family Study (ERF) is a longitudinal study of a
population living in the Rucphen region, The Netherlands, since the 19th
century.24 We selected about 500 individuals with the lowest kinship coefficient
from each population (450 from ERF; 480 from NPSHS and MICROS; 500
from ORCADES and VIS) and an equal amount of DNA from each individual
was used to prepare five population pools with a final DNA concentration of
10 ng/ml. Naturally, the structure of the populations implies that the individuals
included are not completely unrelated.
Four chromosomal regions (LASS4, LIPC, ATP10D and SLC2A9) were
selected for population sequencing based on the associations previously found
between SNPs in these regions and lipid levels (LASS4, LIPC and ATP10D)16 or
uric acid levels (SLC2A9).17 The different regions are defined as follows, with
coordinates in the hg18 genome assembly: (a) LASS4 (LAG1 homolog ceramide
synthase (4), chromosome 19, positions 8 179 257 to 8 234 302, 55 kb, (b) LIPC
(hepatic lipase), chromosome 15, positions 56 450 000 to 56 550 000, 100 kb, (c)
ATP10D (ATPase class V, type 10D), chromosome 4, positions 47 195 000 to
47 299 000, 104 kb and (d) SLC2A9 (solute carrier family 2, member 9),
chromosome 4, positions 9535 000 to 9655 000, 120 kb. The selected regions
span the parts of the genome with SNPs showing the most significant
associations in the previous GWAS.16,17
Enrichment and sequencing
The FastPCR software by Primer Digital Ltd (Helsinki, Finland) (2006–2009) was
used for design of primers for long-range PCR (LR-PCR). Between 30 and 50
primer pairs were designed for each chromosomal region, with an average
amplicon size of 2 kb and 50 to 100 nucleotides overlap. LR-PCR was carried out
in the Veriti thermal cycler (ABI, ABI-Life Technologies, Carlsbad, CA, USA)
using 50ng DNA from the pool in a reaction volume of 100ml, containing 5x HF
buffer, 200mM dNTPs, 12mM of each primer (http://www.sigma.com/oligos)
and 1 unit of Phusion high-fidelity polymerase (Finnzymes, Vantaa, Finland).
A two step PCR was performed with an initial denaturation for 30 s at 981C
followed by 30 cycles of denaturation for 10 s at 981C and extension for 90 s at
721C and a final extension at 721C for 10min. The PCR products were then
subjected to electrophoresis on 1.5% agarose gels (Roche Diagnostic GmbH,
Mannheim, Germany) and visualized by ethidium bromide staining.
Amplicons were purified using the Qiagen Clean-up kit (QIAquick, QIA-
GEN Nordic, Sweden) for PCR products and the concentration was determined
using NanoDrop (NanoDrop Technologies, Thermo Fisher Scientific,
Wilmington, DE, USA). An equal copy number of each amplicon across all
four chromosomal regions was used to prepare an amplicon pool for each
population. The amplicon pool from a population was used to generate a
fragment library and this was used to generate 50 bp sequence reads on the
SOLiD 3 instrument by Applied Biosystems (http://www.appliedbiosystems.-
com). Sequence reads are deposited in the EBI Sequence Read Archive at (SRA)
under the study accession number ERP000249.
PCR errors
Each amplicon was generated by PCR from 100ng genomic DNA (equivalent
to 30 000 copies of a single-copy gene or on average 30 copies of each homolog
in the population sample) from the population pool. With a sequence coverage
of 104 per base and reported per-base error rate of the Phusion DNA
polymerase of 4.4107 (see25), the expected error rate per nucleotide is
4.4103. In the sequencing library, preparation amplicons were amplified
only for a few cycles (n¼3). This could contribute to a bias with respect to the
allelic products that were sequenced and we therefore developed an analysis
strategy that takes into account the number of reads with different unique
starting points in the calling of variants.
Computational strategy to identify SNPs and indels
The different steps of the analysis are described in the sections below.
1. Alignment of sequence reads
2. SNP analysis
(a) Pre-processing and calculating UVAM scores
(b) Calling significant SNPs
(c) Estimating allele frequencies
3. Indel analysis
(a) Split-read alignment and SplitSeek analysis
(b) Estimating allele frequencies
Alignment of sequence reads. The SOLiD reads were aligned to a reference
consisting of the DNA sequence in the ATP10D, LASS4, LIPC and SLC2A9
regions with an additional 10 kb upstream and downstream of each region,
using the SOLiD system analysis pipeline tool (corona lite) and allowing for up
to four mismatches for each 50 bp read. Valid adjacent mismatches were
counted as one mismatch instead of two. The reads that mapped to the target
regions were processed for SNP detection, while the unmapped reads were
analyzed for structural variants (indels).
SNP analysis. The SNP calling strategy can be divided into the two main steps
outlined below. To reduce the effect of variation in coverage between different
regions and populations, an independent analysis was performed for each
region in each of the cohorts. The program code for the SNP analysis is
available upon request.
Pre-processing and calculating UVAM scores The General Feature Format
(GFF) Conversion Tool available from the SOLiD software development
community (http://solidsoftwaretools.com) was used to extract the nucleotide
sequence and mismatches for the aligned reads. To avoid pileups of primer
sequence reads at the ends of our amplicons, we filtered out all reads mapping
to the exact same position and with the same orientation as one of the primers
used in the LR-PCR. Custom programs were implemented to extract the
coverage and valid adjacent mismatches for each position in the sequenced
regions. We also counted the number of uniquely placed reads containing a
valid adjacent mismatch for every position, a value that we labeled ‘unique
valid adjacent mismatches’ (UVAM). UVAM is a robust measurement for SNP
detection, as it is unaffected by pileups of identical reads and insensitive to
variations in coverage. For reads with a length 50 bp the UVAM values range
between 0 and 100, where zero means that no valid adjacent mismatches were
detected at the position. A maximum value of 100 means that there were 50
reads with unique starting points on each of the two strands, which contain a
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valid adjacent mismatch at the given position. As SNPs are reported as valid
adjacent mismatches in the SOLiD system, true SNPs sequenced with high
coverage will be associated with high UVAM values.
Calling significant SNPs We utilized information about the localization of
known SNPs to determine a UVAM cut-off value in the sequenced regions.
First, we extracted the previously computed UVAM scores at all positions
reported in dbSNP and in the 1000 Genomes Project. The UVAM distribution
at known SNP positions in dbSNP and 1000 Genomes Project is shown for the
ATP10D region in the ERF cohort in Figures 1a and b, respectively. The
remaining bases in the sequenced region have a distribution of UVAM scores
that looks fundamentally different (Figure 1c), as the vast majority of such sites
are not polymorphic. This implies that the values at those positions largely
reflect background noise, something we can take advantage of in order to
construct a model for the UVAM distribution at non-SNP sites. Assuming that
s is the total sum of UVAM scores over n non-SNP sites, we modeled the
probability of having a UVAM score of at least k by a binomial approximation
of the hypergeometric distribution.
prob UVAMscore  kð Þ ¼
Xs
i¼k
s
i
 
1=nð Þi 1 1=nð Þsi
The formula above thus models the background distribution of UVAM scores.
This theoretical distribution of UVAM scores for the ATPD10 region is seen in
Figure 1d and is in very good agreement with the empirical values. On the basis
of the P-values we selected a cut-off corresponding to a false discovery rate
(FDR) of 0.01. In the example in Figure 1d, this implied that SNPs at positions
with a UVAM score of at least 14 were called as significant. To increase the
confidence in the SNPs that were detected as novel at the 0.01 FDR level, three
additional criteria were enforced for detection of novel SNPs; (i) at least 95% of
the reads must contain the same alternative nucleotide, (ii) a higher number of
valid adjacent mismatches than all other types of mismatches combined, (iii) at
least 20% of the reads from each of the two strands, and (iv) a total coverage of
at least 1000 reads.
Estimating allele frequencies From the initial mapping, we extracted the
average coverage of each predicted indel, rc, a value that corresponds to the
number of full-length (50 bp) reads that were aligned at the position. If the
number of reads that instead support the predicted insertion or deletion are
denoted by the variable ri, we then estimated the allele frequency for each indel
by the ratio ri/(ri+rc).
Indel analysis. Split-read alignment and SplitSeek analysis All reads that
could not be aligned to the sequenced regions in the alignment step above
(step 1) were used to search for small insertions and deletions by applying
the SplitSeek method, which has previously been used to find splice junctions
and indels in RNA-seq data.26 We first aligned the previously unmapped reads
using the SOLiD split-read alignment program (http://solidsoftwaretools.com),
with the same settings as in the RNA-seq study, and the alignment results were
used as input to SplitSeek.26 We required each indel to be supported by at
least 10 reads from both strands and the maximum length for deletions was set
to 500bp.
Estimating allele frequencies From the initial mapping, we could extract the
average coverage of each predicted indel, rc, which corresponded to the number
of reads that map to the reference sequence. If we denoted the number of reads
that instead support the predicted insertion or deletion by ri, we could then
estimate the allele frequency for each indel by the ratio ri/( ri + rc).
Annotation of SNPs and indels
Version 130 of dbSNP was used for SNP analysis.2 SNP data from the 1000
Genomes Project27 were downloaded from their site (http://www.1000geno-
mes.org) using SNP data files with release date 2009_04.
Experimental validation of novel SNPs
To independently verify the presence of novel, low frequency, SNP, we selected a
set of novel SNP and genotyped these in the 480 individual DNA samples from
the NSPHS cohort that were used to generate the DNA pools, using TaqMan
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Figure 1 UVAM distributions and cut-off for SNP detection for the ATP10D region in the ERF cohort. The UVAM score is a value representing the number of
uniquely placed reads that contain a SNP. The three first panels show the UVAM scores for (a) all positions where a SNP has been reported in dbSNP; (b) all
positions where a SNP has been reported in the 1000 Genomes Project data; (c) all other positions, that is, where no SNPs are reported in dbSNP or in the
1000 Genomes Project; (d) estimated background binomial distribution for UVAM scores. The binomial distribution is used as a model for the UVAM scores
at positions where there are no SNPs. There is a high similarity between the theoretical distribution in (d) and the empirical results in (c). The dotted red
line shows a cut-off level, calculated from the binomial distribution, corresponding to a FDR of 0.01.
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genotyping assays (Applied Biosystems) and the 7900 HT Fast Real Time PCR
system (Applied Biosystems), according to the manufacturer’s instructions.
RESULTS
Analysis overview
We sequenced a total of 286 470 bases (ATP10D 74207 bp, LASS4
34559 bp, LIPC 92226 bp, SLC2A9 85 478 bp) out of the about 397 kb
of the four regions. The parts not covered represent repeated regions
that proved difficult to amplify with long-range PCR. Approximately
300 million reads for the five populations mapped uniquely to the
four chromosomal regions (Supplementary Table S1). To avoid biases
due to oversequencing of reads containing primer sequences, we
removed all reads matching to primer sequences, leaving 263 millions
reads for further SNP analysis. To identify SNPs in the DNA pools, we
developed a computational procedure for SNP and indel identification
(see Methods for details). For each position, we computed the number
of uniquely placed reads that contain a SNP, denoted unique valid
adjacent mismatch (UVAM) scores, and these were used for SNP
calling procedure (Figure 1). Indels were detected through split read
alignment and analysis using the SplitSeek method.26 As an example
the ATPD10 region in the NSPHS cohort when viewed through the
UCSC genome browser28 is shown in Supplementary Figure S1. In
total, 99% of the region under the amplicons has a sequence coverage
of 100 fold, 95% a sequence coverage of 1000 fold and 44% a sequence
coverage of 10 000 fold (Figure 2). This corresponds to a one-fold
coverage per chromosome in the pool for 95% of the sequenced
positions, and a 10-fold coverage per chromosome for 44% of
the sites.
SNP detection and accuracy in allele frequency estimation
To determine our ability to detect SNPs and accurately estimate the
allele frequency, we used genotypes from the Illumina Infinium
HumanHap300v2 array.16 Out of 49, 48 SNPs located in the sequenced
regions were found in at least one of the five cohorts, corresponding to
an analytical sensitivity of 98%. The single SNP (rs11666866) that
could not be detected is located near the end of a PCR primer
sequence, where it was not possible to obtain a sufficient number of
uniquely mapping reads. Of 505 imputed SNPs in the sequenced
regions, only 13 SNPs (3%) were not found in any of the five
populations. These SNPs are either located at the end of the primer
sequences or in the regions with extremely low coverage.
The correlation between the allele frequencies estimated from the
DNA pools and from individual genotypes for the 48 SNPs on the
Illumina array is very high (r2¼0.95) (Po1016) (Figure 3a). There is
also a good correlation between the frequency of imputed SNPs and
those sequenced (r2¼0.91) (Figure 3b). The exception are two SNPs
(rs11736479 and rs7696092), which appear as outliers in all popula-
tions, and both have very low frequencies in HapMap CEU (MAF¼0
and MAF¼0.01) and the rsq value from MACH is o0.30 for all
populations. Rsq is a quality measure by MACH, illustrating the
squared correlation between imputed and true genotypes. Typically, a
cut-off of 0.30 will flag most of the poorly imputed SNPs. To examine
the effect of sequence coverage on the precision of the allele frequency
estimate, we studied SNPs with a coverage of410 000 fold (n¼1059)
(Figure 3c) and o2000 fold (n¼186) (Figure 3d). The correlation
even at lower sequence coverage is still very high (r2¼0.89). The results
show that method can be used to estimate the frequency of SNPs in a
pool of DNA samples and is useful at different sequence coverage
levels.
Experimental validation of novel SNPs
A set of novel SNPs detected in the NSPHS cohort were genotyped
using TaqMan genotyping assays on the individual DNA samples. We
selected the SNPs uniformly across the allele frequency spectrum, with
predicted MAF from about 8% to below 1%. All 12 SNPs genotyped
were identified (see Supplementary Table S2), and the correlation
between the allele frequency estimated from the DNA pools and from
individual genotyping is very high (r2¼0.95) (Figure 3e). These results
shows that our method can identify novel SNPs with high sensitivity
for novel/rare SNPs and predict accurate allele frequencies for rare
SNPs with MAF at 5% or below.
SNP and indel discovery
We identified 1884 SNPs in the five population cohorts and four
chromosomal regions (Table 1). Of the SNPs, 17% (318/1884) are not
present in dbSNP version 130 or in the 1000 Genomes Project data
(release date 2009_04). Among structural variants 61% (63/103) are
not present in dbSNP (Table 1). In all, 81% (257/318) of novel SNPs
occur at a frequency of 5% or less (Supplementary Figure S2a). Of the
SNPs with a frequency of up to 5% and identified in all five
populations, 37% (257/697) are not available in any database
(Table 2). As many as 81% of the indels with a frequency up to 5%
are not available in the public databases (Supplementary Figure S2b).
Some deletions have lengths up to 100 bp or more but the majority of
them are small (1–5 bp) (Supplementary Figure S3). A similar analysis
for insertions is presently not possible due to technical reasons. The
complete lists of all SNPs and indels detected in each of the five
populations are available as supplementary data files.
Comparisons between populations
The majority of SNPs are found in more than one of the cohorts. Of
all SNPs in the five cohorts, 63% are common to all cohorts and 19%
are found in only one cohort (Figure 4a). Of the novel SNPs, only 6%
is present in all cohorts and about 62% is only found in one
(Figure 4b). In total, 93–136 novel SNPs are found per cohort
(Table 1). In all, 46% (323/697) of SNPs with frequency of 5% or
less and 67% (177/263) with a frequency of 1% or less are found in
only one of the five cohorts (Table 2). Of all indels, 38% are common
to all cohorts (Figure 4c), while among the novel indels 21% are
common to all cohorts (Figure 4d). Of all indels, 40% are found in
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only one of the cohorts. When only considering novel indels, the
corresponding percentage is 59%.
DISCUSSION
We have shown that long-range PCR and deep DNA sequencing can
be used to identify SNPs and structural variation in high-complexity
DNA pools. Pooling of DNA samples substantially increases the
efficiency of sequencing studies29 and has previously been used to
sequence selected regions in pools of DNA samples or pools of
amplicons.9,11,12,30
Using an analysis strategy that require a SNP or indel to be found in
several reads with different alignment positions, in combination with
using the SOLiD two-base encoding, we show that low frequency
variants can be identified with high confidence. The allele frequencies
estimated from the DNA pools show very good correlation with
frequencies based on individual genotypes, as well as imputed SNPs.
Validation of candidate novel SNPs also supported our procedure for
SNP identification. For detection of indels, we used a method initially
developed to study splice variation in RNA-seq data.26 As only one
algorithm was used for indel detection and the predicted indels were
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Figure 3 Correlation between the allele frequencies estimated by sequencing of pools (x axes) and from individual genotyping (y axes). Correlation for (a)
SNPs genotyped on the array (n¼240); (b) SNPs where the array frequencies were inferred by imputation (n¼2217); (c) SNPs with at least 10000 fold
coverage (n¼1059) and where the array frequencies were inferred by imputation; and (d) SNPs with at most 2000-fold coverage (n¼186) and where the
array frequencies were inferred by imputation; (e) comparison of the allele frequencies for of a set of novel low frequency SNPs detected by the method and
by individual TaqMan genotyping in 480 individuals from the NSPHS cohort.
Table 1 Summary of the number of SNPs and indels found in the sequencing of DNA pools from the five EUROSPAN populations
Number of detected variants Number of variants in one population only
ERF MIC NSP ORC VIS Total ERF MIC NSP ORC VIS Total
SNPs
Total 1431 1488 1504 1439 1426 1884 73 62 118 51 57 361
In dbSNP 130 1121 1153 1159 1130 1132 1217 4 6 18 5 11 44
In 1000 genomes 1219 1269 1310 1256 1252 1459 17 12 51 22 19 121
Novel 128 136 114 97 93 318 52 44 49 24 27 196
Indels
Total 53 58 69 63 57 103 4 10 12 8 7 41
In dbSNP 130 32 32 38 31 32 40 0 0 3 0 1 4
Novel 21 26 31 32 25 63 4 10 9 8 6 37
Abbreviations for population cohorts: MIC, MICROS; NSP, NSPHS; ORC, ORCADES.
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not experimentally validated, we cannot exclude that some of them
may represent false positives. However, the algorithm used is only able
to detect indels of a certain size, thus inherently underestimating the
total number. Also, we used stringent criteria in the variant calling
(ie, number of reads supporting an indel), which will reduce the
number of false positive calls. Another factor that affects the number
of novel SNPs and indels detected is sequence coverage. The average
sequence coverage ranges from 6000 fold to 13 000 fold with 95% of
the bases having a coverage of 1000 fold in a DNA pool of 1000
chromosomes. This means that we are likely not to have identified all
genetic variants present, and deeper sequencing would have resulted in
additional variants. This is supported by our results, where we find
that the average coverage for rare variants (MAFo1%) is about
16 000, while it is lower (around 10 000) among the other SNPs.
We studied populations from different parts of Europe, encom-
passing much of the genetic diversity present on the European
continent. In the sequencing of 100 kb in 692 samples from 10 global
populations, the HapMap 3 Consortium found that 77% of SNPs are
not in dbSNP (build 129) and of these 99% had a MAFo5%.5 By
comparison, 26% of all SNPs in our cohorts are not in dbSNP and of
novel SNPs, 81% had a MAFo 5% (Tables 1 and 2). The low-coverage
sequencing in the 1000 Genomes project similarly reported an overall
frequency of novel SNPs of 54% and novel indels of 57%.7 The novel
low frequency variants tend to be found only in a limited set of
populations and 62% of novel SNPs and 59% of structural variants are
found in only one of our five cohorts. Among SNPs with a MAF
o0.5%, 88% were found in only one of our cohorts, as compared to
37% in the HapMap 3 study.5 In the 1000 Genomes Project pilot
study, 25% of SNPs already reported in dbSNP (vers129) were
detected in only one of the population panels, while as many as
84% of novel SNPs was found in a single panel.7 The difference seen
between studies in the frequency of variants that is found only in a
single population/panel may reflect both the sample size and extent of
geographic region covered. The 1000 Genomes Project and HapMap 3
Consortium panels include sampling from the major human popula-
tions groups (ie, African, European and Asian populations), but with a
more limited sample size per population (about 50–100 individuals),
while our five populations have been sampled at a much higher depth.
Table 2 Detection of SNPs with different frequencies in the total
material
Allele
frequency
(%)
Total
SNPs
In
dbSNP
In 1000
genomes,
not in dbSNP
Novel
(% of total)
Present only in
one population
(% of total)
r0.1 10 1 9 0 (0) 8 (80)
r0.5 140 32 92 16 (11) 103 (74)
r1 263 56 144 63 (24) 177 (67)
r2 434 91 195 148 (34) 242 (56)
r3 539 112 227 200 (37) 281 (52)
r5 697 166 274 257 (37) 323 (46)
r10 929 325 310 294 (32) 350 (38)
r20 1136 493 336 307 (27) 357 (31)
420 748 724 13 11 (1) 4 (1)
Total 1884 1217 349 318 (17) 361 (19)
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Figure 4 Number of overlapping SNPs and indels between the five populations. The five bars in each of the panels indicate the number of populations, in
which the variants are found. The panels show the results for (a) all detected SNPs; (b) novel SNPs, that is, those not in dbSNP or the 1000 Genomes
Project; (c) all detected in-dels; (d) novel indels, that is, those not in dbSNP.
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The observation that over 50% of the novel SNPs in our study show a
very restricted geographic distribution attests to the large amount of
genetic variation present in local populations within the European
continent.
Extrapolating from our results to a genome-wide scale this corre-
sponds to about 3.7 million novel SNPs (between 1.1–1.6 million per
population) and 0.7 million indels (between 0.2–0.4 million indels per
population). The 1000 Genomes Project low coverage sequencing
identified about eight novel million SNPs in all three population
panels, with 1.7–5.1 novel million SNPs per panel and 0.75 million
novel indels, with 0.3–0.5 million per panel. The 1000 Genomes
Project cover about 86% of the genome, including both genic and
intergenic regions and span major human population groups. It is
therefore surprising that deep sequencing of populations from a much
more limited geographic area can yield similar high numbers of
genetic variants. Given the large number of novel low frequency
variants identified, many of which show a limited distribution, future
association studies based on cohort sequencing will have to consider
careful population matching of cases and controls. Until the sequen-
cing technology becomes affordable to perform sequencing of thou-
sands of individuals per population, DNA pools remains a practical
alternative.
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